Vascular toxicity of tyrosine kinase inhibitors: Pulmonary hypertension Book Section
| Author: | Yu, A. F. |
| Editors: | Steingart, R. M.; Liu, J. E. |
| Article/Chapter Title: | Vascular toxicity of tyrosine kinase inhibitors: Pulmonary hypertension |
| Abstract: | A 41-year-old woman was diagnosed with CML and treated in the first-line setting with dasatinib, a second-generation BCR-ABL TKI. After 2 years of treatment, she achieved a major molecular response but reported new dyspnea on exertion. © Springer Nature Switzerland AG 2021 R. M. Steingart et al. (eds.). |
| Keywords: | dasatinib; tyrosine kinase inhibitors; pulmonary hypertension; bosutinib; ibrutinib; right ventricle |
| Book Title: | Atlas of Imaging in Cardio-Oncology: Case-Based Study Guide |
| ISBN: | 978-3-030-70997-6 |
| Publisher: | Springer |
| Publication Place: | Cham, Switzerland |
| Date Published: | 2021-01-01 |
| Start Page: | 57 |
| End Page: | 58 |
| Language: | English |
| DOI: | 10.1007/978-3-030-70998-3_9 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Book chapter: 9 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work